m5l9e3q | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/2m5l9e3q_hasAnnotation_C0060983>
?:creator	<https://research.tib.eu/covid-19/entity/de_la_Fuente%2C_Jos%C3%A9%3B_Gort%C3%A1zar%2C_Christian%3B_Cabezas-Cruz%2C_Alejandro>
?:doi	<https://research.tib.eu/covid-19/entity/10.2217/imt-2020-0247>
?:doi	10.2217/imt-2020-0247
?:journal	Immunotherapy
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/57b9c709acda29dd296e5335a3335bbf4637afac.json
?:pmc_json_files	document_parses/pmc_json/PMC7735019.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7735019>
?:pmid	<https://research.tib.eu/covid-19/entity/33307805.0>
?:pmid	33307805.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/2m5l9e3q_HAS_C0060983_AFFECTS_C5203670>
?:sha_id	<https://research.tib.eu/covid-19/entity/57b9c709acda29dd296e5335a3335bbf4637afac>
?:source	Medline; PMC
?:title	Immunity to glycan α-Gal and possibilities for the control of COVID-19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-14

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/2m5l9e3q>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/2m5l9e3q>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all